Issues on Results of the External Quality Assessment for Proviral DNA Testing of HIV-1 Tropism in the Maraviroc Switch Collaborative Study
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Svicher V, Alteri C, Montano M, DArrigo R, Andreoni M, Angarano G
. Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. New Microbiol. 2012; 35(1):17-25.
View
2.
Svicher V, Cento V, Rozera G, Abbate I, Santoro M, Armenia D
. The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing. PLoS One. 2013; 8(1):e53603.
PMC: 3544916.
DOI: 10.1371/journal.pone.0053603.
View
3.
Symons J, Vandekerckhove L, Paredes R, Verhofstede C, Bellido R, Demecheleer E
. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice. Clin Microbiol Infect. 2011; 18(6):606-12.
DOI: 10.1111/j.1469-0691.2011.03631.x.
View
4.
Tu E, Swenson L, Land S, Pett S, Emery S, Marks K
. Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study. J Clin Microbiol. 2013; 51(7):2063-71.
PMC: 3697703.
DOI: 10.1128/JCM.00510-13.
View
5.
Paar C, Geit M, Stekel H, Berg J
. Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory. J Clin Microbiol. 2011; 49(7):2697-9.
PMC: 3147877.
DOI: 10.1128/JCM.00336-11.
View